The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022
DSIP works differently from sedatives and sleep aids
La technologie ZetaGreen repose sur la conception de liposomes secs, particulirement stables, capables dassurer une protection optimale du glutathion rduit jusqu son assimilation intestinale
They operate at fundamentally different points in the endocrine cascade, and conflating them leads to failed research protocols